New glasses could slow Kids' worsening eyesight
NCT ID NCT07387159
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests special glasses called MiYOSMART iQ that use tiny lens segments to create a blur signal on the side of the eye, which may slow down the worsening of nearsightedness in children. About 35 kids aged 8-11 will wear these glasses for 6 months, and their results will be compared to a similar group from past data. The goal is to see if these lenses can reduce how much the eye grows longer, which is what makes nearsightedness worse.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
MiYOSMART iQ spectacle lenses with Defocus Incorporated Multiple Segments (DIMS) technology
What this could lead to
If successful, these lenses could offer a non-invasive way to slow down worsening nearsightedness in children, reducing the need for stronger prescriptions over time.
What could go wrong
This is a small, early-stage study with only 35 children receiving the lenses, compared to a historical control group. Results may not apply to all children, and long-term effects beyond 6 months are unknown.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYOPIA, CHILD MYOPIA PROGRESSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Helmholtz National Medical Research Center of Eye Diseases
RECRUITINGMoscow, 105062, Russia
Contact Phone: •••-•••-•••• Email: •••••@•••••